FAKTOR-OPTIONSSCHEIN - GILEAD SCIENCES Share Price

Certificat

DE000MC2VP59

Market Closed - Börse Stuttgart 20:03:07 14/06/2024 BST
3.81 EUR +8.86% Intraday chart for FAKTOR-OPTIONSSCHEIN - GILEAD SCIENCES
Current month+8.86%
1 month-9.72%
Date Price Change
14/06/24 3.81 +8.86%
13/06/24 3.5 -1.69%
12/06/24 3.56 -2.47%
11/06/24 3.65 -0.27%
10/06/24 3.66 -0.27%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 08:03 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying GILEAD SCIENCES, INC.
Issuer Morgan Stanley
WKN MC2VP5
ISINDE000MC2VP59
Date issued 25/07/2019
Strike 42.02 $
Maturity Unlimited
Parity 5.67 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 19.21
Lowest since issue 3.32
Spread 0.01
Spread %0.26%

Company Profile

Gilead Sciences, Inc. specializes in the development, manufacturing and marketing of therapeutic products. Net sales break down by source of income as follows: - sale of drugs (98.9%): for the treatment of HIV (63% of net sales), COVID-19 (20.4%), hepatitis C virus (6.6%), hepatitis B virus (3.6%) and other (6.4%; primarily cytomegalovirus retinitis, and advanced Kaposi sarcoma resulting from HIV); - other (1.1%): especially royalties and revenue from research and development services and from subcontracted production of therapeutic products. Net sales are distributed geographically as follows: the United States (69.2%), Europe (16.4%) and other (14.4%).
Sector
-
More about the company

Ratings for Gilead Sciences, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Gilead Sciences, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
65.06 USD
Average target price
82.7 USD
Spread / Average Target
+27.11%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW